A Role for Chromosomal Microarray Testing in the Workup of Male Infertility.
Chromosome Deletion
Chromosomes, Human, Y
/ genetics
Cohort Studies
Cytogenetic Analysis
/ methods
Data Accuracy
Genetic Testing
/ methods
Humans
Infertility, Male
/ diagnosis
Karyotype
Karyotyping
/ methods
Male
Mosaicism
Multiplex Polymerase Chain Reaction
/ methods
Polymorphism, Genetic
Sex Chromosome Aberrations
Sex Chromosome Disorders of Sex Development
/ diagnosis
Journal
The Journal of molecular diagnostics : JMD
ISSN: 1943-7811
Titre abrégé: J Mol Diagn
Pays: United States
ID NLM: 100893612
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
04
10
2019
revised:
28
04
2020
accepted:
18
06
2020
pubmed:
3
7
2020
medline:
28
8
2021
entrez:
3
7
2020
Statut:
ppublish
Résumé
Genetic analysis is a critical component in the male infertility workup. For male infertility due to oligospermia/azoospermia, standard guidelines recommend karyotype and Y-chromosome microdeletion analyses. A karyotype is used to identify structural and numerical chromosome abnormalities, whereas Y-chromosome microdeletions are commonly evaluated by multiplex PCR analysis because of their submicroscopic size. Because these assays often require different Vacutainer tubes to be sent to different laboratories, ordering is prone to errors. In addition, this workflow limits the ability for sequential testing and a comprehensive test result. A potential solution includes performing Y-microdeletion and numerical chromosome analysis-the most common genetic causes of oligospermia/azoospermia-by chromosomal microarray (CMA) and reflexing to karyotype as both assays are often offered in the cytogenetics laboratory. Such analyses can be performed using one sodium heparin Vacutainer tube sample. To determine the effectiveness of CMA for the detection of clinically significant Y-chromosome microdeletions, 21 cases with known Y microdeletions were tested by CytoScan HD platform. CMA studies identified all known Y-chromosome microdeletions, and in 11 cases (52%) identified additional clinically important cytogenetic anomalies, including six cases of 46, XX males, one case of isodicentric Y, two cases of a dicentric Y, and three cases of terminal Yq deletions. These findings demonstrate that this testing strategy would simplify ordering and allow for an integrated interpretation of test results.
Identifiants
pubmed: 32615168
pii: S1525-1578(20)30372-X
doi: 10.1016/j.jmoldx.2020.06.009
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1189-1198Informations de copyright
Copyright © 2020 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.